APP and Alzheimer disease: To examine the ability and flexibility of the Cas9nVQR variant to manipulate gene copy number in iPSCs at the single-cell-derived clone level, we utilized an AD iPSC line carrying APP duplication (i.e., APP cells)9 and targeted APP exon 16, which is inaccessible to wild-type Cas9n (Fig. 1a).